POLE mutations and MSI were positive predictive factors for progression free survival in endometrial cancer patients at the risk of recurrence

Authors :: Keiichiro Nakamura
Tomoko Haruma
Takeshi Nishida
Takeshi Nagasaka
Ajay Goel
Junko Haraga
T. Fujiwara
Kazuya Yasui
Akihiro Nyuya
Hisashi Masuyama
Source :: Annals of Oncology. 28:v335-v336
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Internal medicine
Endometrial cancer
Medicine
Hematology
Progression-free survival
business
medicine.disease

Full Text Access

Tools